|
|
Have questions? Please email [email protected].
January 9, 2026 | 9:00 AM - 12:00 PM
An Introduction to Psychedelic Assisted Therapy for Oregon Psychologists presented by Brian Pilecki, PhD, Jason Luoma, PhD, Jenna LeJeune, PhD, Kyong Yi, LCSW

Presentation Description/Summary:
Psychedelic-assisted therapy is showing promise as a highly effective form of mental health treatment and appears poised to become a major new form of mental health care moving forward. Patients participating in psychedelic-assisted therapy often relate that their sessions were among the most meaningful experiences in their life, often rating them similarly to events like the birth of a first child or getting married. Thus, these interventions don‘t just reduce suffering, they appear to increase meaning-making, fulfillment, and positive mental health. This workshop, led by presenters currently running clinical trials of this type of therapy, will provide psychologists with an evidence-based overview of this new clinical area. Differences between the most common psychedelics will be outlined and results from the most recent and rigorous clinical trials will be summarized. The basic model of psychedelic-assisted psychotherapy using ACT and CBT models will be explained with an emphasis on highlighting the importance of preparation and integration in obtaining therapeutic benefits from a psychedelic experience. Mechanisms of change will be discussed, including intriguing findings suggesting that psychedelic-assisted therapy may functions more through increasing positive functioning, meaning, self-transcendence, flexibility, interpersonal engagement, and fulfillment rather than directly reducing symptoms. The current legal status of psychedelics will be reviewed, including recent state level initiatives in Oregon toward legal psychedelic service access. Diversity and equity issues will be reviewed including lack of access for underserved and non-majority populations and the risks of cultural appropriation involved in modern psychedelic science. We will also provide recommendations on obtaining further training for those who want to learn more. This workshop will help clinicians understand the current state of psychedelic science, as well as to have more informed and evidence-based conversations with clients about psychedelics and their potential risks and benefits, legal status, and timeline for public accessibility.
Learning Outcomes:
Participants will be able to describe the theory and practice of psychedelic assisted psychotherapy. Participants will be able to summarize research findings and current legal status of psychedelic assisted psychotherapy. Participants will be able to describe the role of psychotherapy in preparation for and integration of psychedelic experiences.
Brian Pilecki, PhD is a clinical psychologist at Portland Psychotherapy that specializes in the treatment of anxiety disorders, trauma and PTSD, and psychedelic-assisted therapy. At Portland Psychotherapy, Brian is an active researcher and a study therapist on several clinical trials including the investigation of the use of MDMA-assisted therapy for the treatment of social anxiety disorder and the use of 5-MeO-DMT for the treatment of treatment-resistant depression. He is a consultant and instructor for Fluence, a leading psychedelic training organization where he is involved in training psilocybin facilitators for Oregon’s new psilocybin services program. Brian is also a co-founder of Portland Integration Network, a network of professionals offering specialized care related to psychedelics in Oregon. He is also the author of the book ACT-Informed Exposure for Anxiety and co-host of Altered States of Context, a podcast about psychotherapy and psychedelics.
Jason Luoma, PhD is a Portland-based researcher, entrepreneur, clinical psychologist, and psychotherapy trainer whose work since 2002 has focused on shame, self-criticism, stigma, and the interpersonal functions of emotion. He has been active in psychedelic science since 2018, conducting one of the first MDMA-assisted psychotherapy trials in the Pacific Northwest, and has served as a co-investigator, consultant, therapist, and trainer on NIH-funded projects; he also co-founded the Open Psychedelic Evaluation Nexus to evaluate Oregon’s state-legal psilocybin services. A widely published author and co-author of two leading ACT books, he has founded and led mission-driven organizations for more than two decades, including the Portland Psychotherapy Clinic, Research, & Training Center, and is the creator of the ACT with compassion blog and The Research Matters Podcast. A peer-reviewed ACT trainer and former president of the Association for Contextual Behavioral Science with additional training in RO-DBT and emotion-focused therapy, he provides workshops and seminars through portlandpsychotherapytraining.com, including the Therapy and Research in Psychedelic Science (TRIPS) series.
Jenna LeJeune, Ph.D., is President and co-founder of Portland Psychotherapy Clinic, Research and Training Center in Portland, Oregon. She is also a study therapist at the Portland Institute for Psychedelic Science, where she is involved in various clinical trials of psychedelic-assisted psychotherapy. As a licensed psychologist, Jenna is deeply interested in issues related to meaning, purpose, belonging, and values. In her clinical practice, Jenna specializes in Acceptance and Commitment Therapy (ACT), helping those she serves connect with what is most meaningful so they are able to live lives of purpose and integrity even in the midst of suffering. She is the co-author of the book Values in Therapy: A Clinician's Guide to Helping Clients Explore Values, Increase Psychological Flexibility, and Live a More Meaningful Life, as well as numerous other book chapters, journal articles, and other publications. Dr. LeJeune is also a Fellow of the Association for Contextual Behavioral Science and a peer-reviewed ACT trainer and provides ACT trainings for professionals around the world.
Kyong Yi, LCSW, is a therapist and the Director of Clinical Operations at the Portland Psychotherapy Clinic, Research, and Training Center in Portland, Oregon. She specializes in treating trauma and relational concerns through the lenses of Acceptance and Commitment Therapy (ACT) and Emotion-Focused Therapy (EFT). Kyong has served as a study therapist on several clinical trials at Portland Psychotherapy, including research on MDMA-assisted therapy for social anxiety disorder. She is an approved consultant with MAPS PBC/Lykos, providing supervision and mentorship to emerging practitioners of MDMA-assisted therapy. In addition, Kyong is a licensed psilocybin facilitator in Oregon, offering both individual and group psilocybin facilitation.
The Oregon Psychological Association sponsors many continuing education programs that have been developed to meet the needs of psychologists and other mental health professionals. The Continuing Education Committee works diligently to provide programs that are of interest to the wide variety of specialties in mental health.
Level 1: general or introductory content aimed at a diverse audience.
Level 2: psychologically sophisticated content, at either introductory or more advanced levels, aimed at general professional audiences.
Level 3: highly advanced theoretical or technical content, aimed at expert audiences.
Level 2 and 3 presentations will typically warrant CE credit for a licensed psychologist. Both level and number of hours for each workshop are indicated for each workshop and official letters of completion will be awarded to participants who attend the entire workshop. APA guidelines specify that no letter of attendance will be awarded for partial workshop attendance.
Level 2 and 3 offerings are typically accepted by the Oregon Board of Psychologists (OBOP). However, Oregon licensed psychologists should consult with the Oregon Board of Psychologists regarding the state laws and rules regarding continuing education in Oregon, and note that there is no pre-certification of continuing education credit by the Oregon Board of Psychologists. If you have questions about whether or not OBOP may accept a class for CE credit you can contact them at 503.378.4154.

Cultural Competence Homestudy courses are offered by the New Mexico Psychological Association (NMPA) to OPA members for a fee. Questions should be directed to the NMPA. Courses include: Cultural Competency Assessment (1 CE), Multicultural Counseling Competencies/Research (2 CEs), Awareness-based articles (3 CE), Knowledge based articles (3 CE), Skills-based articles on counseling (3 CE) and Skills-based articles on assessment (3 CE). Click on the link above to get started.
In order to register for OPA webinars on-line you will need a credit card for payment to complete your order. Please review the cancellation policy for each event carefully.
All OPA educational events are provided in a virtual format only. If you are unable to attend virtually the day of the webinar, you can now register for the recorded only version and a link to the recording of the webinar will be emailed to you approximately one week after the webinar concludes.